NCT01562600

Nexium Capsules Non-steroidal Anti-inflammatory Drug (NSAID) Specific Clinical Experience Investigation

Nexium Capsules Specific Clinical Experience Investigation for Long-term Use Concerning Prevention of Recurrence of Gastric Ulcer or Duodenal Ulcer With NSAIDs

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,634 (actual)
• Sponsor: AstraZeneca · Industry
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The purpose of this investigation is to collect following data in patients given Nexium capsule (Nexium) for long term in usual-post-marketing therapy to prevention of recurrence of gastric ulcer or duodenal ulcer with non-steroidal anti-inflammatory drug (NSAID).

Detailed description

Nexium capsules Specific Clinical Experience Investigation for long-term use concerning prevention of recurrence of gastric ulcer or duodenal ulcer with NSAIDs

Conditions

• Gastric Ulcer
• Duodenal Ulcer

Timeline

• Start date: 2012-04-19
• Primary completion: 2015-08-27
• Completion: 2015-08-27
• First posted: 2012-03-26
• Last updated: 2019-08-07

Locations

46 sites across 1 country: Japan